{"organizations": [], "uuid": "e9bc84dd2e16d73b43c4d4197ee565c683e6a06b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Renal-Cancer-Treatment-3A-Industry-Analysis--R-26amp-3BD-Trends-and-World-Market-Forecasts-2015-2025-49015-1/", "country": "US", "title": "Renal Cancer Treatment: Industry Analysis, R&D Trends and World Market Forecasts 2015-2025", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Renal Cancer Treatment: Industry Analysis, R&D Trends and World Market Forecasts 2015-2025", "spam_score": 0.0, "site_type": "news", "published": "2015-10-16T16:40:00.000+03:00", "replies_count": 0, "uuid": "e9bc84dd2e16d73b43c4d4197ee565c683e6a06b"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Renal-Cancer-Treatment-3A-Industry-Analysis--R-26amp-3BD-Trends-and-World-Market-Forecasts-2015-2025-49015-1/", "ord_in_thread": 0, "title": "Renal Cancer Treatment: Industry Analysis, R&D Trends and World Market Forecasts 2015-2025", "locations": ["LONDON"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "LONDON , October 16, 2015 /PRNewswire/ -- \nKidney Cancer Therapies - Now Explore Potentials of New Drugs, Industry Changes and Emerging Opportunities Are you interested in the future of renal cancer treatments ? Our new study forecasts those pharmaceutical revenues. There you find outlooks for sales growth in that industry. You also explore trends, results, treatments, R&D and opportunities, seeing commercial prospects. \nVisiongain 's report gives revenue predictions to 2025 at overall world market, submarket, product and national level. Avoid falling behind in data or losing influence. Instead discover, from 2015, what progress, opportunities and sales are possible for those cancer treatments. \nRead on, then, to explore renal cancer therapy and see what future revenues that expanding pharma market could generate. \nForecasts and other analysis to benefit your research, assessments, plans and decisions With our new study you explore prospects for companies developing, producing and marketing drugs for treating cancer of the human kidneys. See present trends and future possibilities. \nBesides revenue forecasting to 2025, our new work shows recent results, sales growth rates and market shares. There you find original analysis. Assess research and development too, seeing prospects. Also get 51 tables, 38 charts and two interviews with companies. \nSo avoid missing out on original data and discussions to help your work. \nR&D and opportunities for sales growth - explore trends and forecasts, staying ahead Our study's purpose is to help your research, analyses and decisions on those renal therapies, also benefiting your authority and reputation for insight. \nThe future looks promising for pharma companies treating those cancers . Discover the progress and gains possible there, avoiding struggles to find business information you need. See, from 2015, how patients, healthcare providers and companies can benefit. \nVisiongain 's analysis shows how the industry for renal cancer treatments evolves. New products enter that market and novel drug candidates reach late-stage clinical trials. Discover what future revenues are possible in that expanding pharma sector. \nAlthough no single study covers everything, the following sections show how our new investigation benefits your work. \nForecasts covering the overall world market and segments for treating kidney cancer Discover in our new report forecasted world revenue to 2025 for those anticancer medicines - existing, emerging and expected drugs . \nYou also gain individual revenue predictions to 2025 for five submarkets at world level. See what is possible for these therapeutic classes:â€¢ Angiogenesis inhibitors", "external_links": [], "published": "2015-10-16T16:40:00.000+03:00", "crawled": "2015-10-16T17:45:38.311+03:00", "highlightTitle": ""}